Published Date：Nov. 2020
Industry：Medical Devices & Consumables
Pages：101 Table Number：126
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Thrombin market in this environment. In terms of revenue, this research report indicated that the global Thrombin market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Thrombin industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The ?Pfizer aims at producing XX Thrombin in 2020, with XX % production to take place in global market, ????Johnson & Johnson Services accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Thrombin Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Thrombin Market? Pfizer Johnson & Johnson Services Octapharma Baxter Bayer CSL Grifols GE Healthcare Hualan Biological ... Major Type of Thrombin Covered in XYZResearch report: Bovine Thrombin Human Thrombin Recombinant Thrombin Application Segments Covered in XYZResearch Market Hospitals Diagnostics Centers & Clinics Academics & Research Institutes For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Thrombin Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Bovine Thrombin -Product Introduction and Major Manufacturers 1.1.2 Human Thrombin -Product Introduction and Major Manufacturers 1.1.3 Recombinant Thrombin -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Thrombin Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Thrombin Market 3.1.1 Top Companies leading Thrombin Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Thrombin Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Thrombin Market 3.2.1 Top Companies leading Thrombin Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Thrombin Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Thrombin Market 3.3.1 Top Companies leading Thrombin Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Thrombin Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Thrombin Market 3.4.1 Top Companies leading Thrombin Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Thrombin Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Thrombin Market 3.5.1 Top Companies leading Thrombin Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Thrombin Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Thrombin Market 3.6.1 Top Companies leading Thrombin Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Thrombin Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Thrombin Market 3.7.1 Top Companies leading Thrombin Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Thrombin Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Thrombin Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Thrombin Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Thrombin Sales and Growth Rate (2021-2026) 5.2 Global Thrombin Sales Value and Growth Rate (2021-2026) 6 Thrombin Competitive Analysis 6.1 Pfizer 6.1.1 Pfizer Company Profiles 6.1.2 Pfizer Product Introduction 6.1.3 Pfizer Thrombin Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Johnson & Johnson Services 6.2.1 Johnson & Johnson Services Company Profiles 6.2.2 Johnson & Johnson Services Product Introduction 6.2.3 Johnson & Johnson Services Thrombin Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Octapharma 6.3.1 Octapharma Company Profiles 6.3.2 Octapharma Product Introduction 6.3.3 Octapharma Thrombin Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Baxter 6.4.1 Baxter Company Profiles 6.4.2 Baxter Product Introduction 6.4.3 Baxter Thrombin Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 Bayer 6.5.1 Bayer Company Profiles 6.5.2 Bayer Product Introduction 6.5.3 Bayer Thrombin Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 CSL 6.6.1 CSL Company Profiles 6.6.2 CSL Product Introduction 6.6.3 CSL Thrombin Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 Grifols 6.7.1 Grifols Company Profiles 6.7.2 Grifols Product Introduction 6.7.3 Grifols Thrombin Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 GE Healthcare 6.8.1 GE Healthcare Company Profiles 6.8.2 GE Healthcare Product Introduction 6.8.3 GE Healthcare Thrombin Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 6.9 Hualan Biological 6.9.1 Hualan Biological Company Profiles 6.9.2 Hualan Biological Product Introduction 6.9.3 Hualan Biological Thrombin Production, Revenue (2015-2020) 6.9.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Thrombin Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Thrombin Sales (K Unit) by Type (2015-2026) Figure Global Thrombin Sales (K Unit) and Growth Rate (2015-2026) Figure Global Thrombin Sales Market Share (%) by Type (2019 -2020) Table Global Thrombin Sales Value (Million USD) by Type (2015-2026) Figure Global Thrombin Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Thrombin Sales Value Market Share (%) by Type (2019-2020) Table Global Thrombin Sales (K Unit) by Application (2015-2026) Table China Thrombin Sales (K Unit) of Major Company (2015-2020) Table China Thrombin Sales Market Share of Major Company (2015-2020) Table China Thrombin Sales Value (Million USD) of Major Company (2015-2020) Figure China Thrombin Sales Value (Million USD) and Growth Rate (2015-2020) Table China Thrombin Sales Value Share of Major Company (2015-2020) Table China Thrombin Price (USD/Unit), by Type (2019-2020) Table China Thrombin Sales (Unit) by Type (2015-2026) Figure China Thrombin Sales (Unit) by Type (2015-2026) Table EU Thrombin Sales (K Unit) of Major Company (2015-2020) Table EU Thrombin Sales Market Share of Major Company (2015-2020) Table EU Thrombin Sales Value (Million USD) of Major Company (2015-2020) Figure EU Thrombin Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Thrombin Sales Value Share of Major Company (2015-2020) Table EU Thrombin Price (USD/Unit), by Type (2019-2020) Table EU Thrombin Sales (Unit) by Type (2015-2026) Figure EU Thrombin Sales (Unit) by Type (2015-2026) Table USA Thrombin Sales (K Unit) of Major Company (2015-2020) Table USA Thrombin Sales Market Share of Major Company (2015-2020) Table USA Thrombin Sales Value (Million USD) of Major Company (2015-2020) Figure USA Thrombin Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Thrombin Sales Value Share of Major Company (2015-2020) Table USA Thrombin Price (USD/Unit), by Type (2019-2020) Table USA Thrombin Sales (Unit) by Type (2015-2026) Figure USA Thrombin Sales (Unit) by Type (2015-2026) Table Japan Thrombin Sales (K Unit) of Major Company (2015-2020) Table Japan Thrombin Sales Market Share of Major Company (2015-2020) Table Japan Thrombin Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Thrombin Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Thrombin Sales Value Share of Major Company (2015-2020) Table Japan Thrombin Price (USD/Unit), by Type (2019-2020) Table Japan Thrombin Sales (Unit) by Type (2015-2026) Figure Japan Thrombin Sales (Unit) by Type (2015-2026) Table India Thrombin Sales (K Unit) of Major Company (2015-2020) Table India Thrombin Sales Market Share of Major Company (2015-2020) Table India Thrombin Sales Value (Million USD) of Major Company (2015-2020) Figure India Thrombin Sales Value (Million USD) and Growth Rate (2015-2020) Table India Thrombin Sales Value Share of Major Company (2015-2020) Table India Thrombin Price (USD/Unit), by Type (2019-2020) Table India Thrombin Sales (Unit) by Type (2015-2026) Figure India Thrombin Sales (Unit) by Type (2015-2026) Table Southeast Asia Thrombin Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Thrombin Sales Market Share of Major Company (2015-2020) Table Southeast Asia Thrombin Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Thrombin Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Thrombin Sales Value Share of Major Company (2015-2020) Table Southeast Asia Thrombin Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Thrombin Sales (Unit) by Type (2015-2026) Figure Southeast Asia Thrombin Sales (Unit) by Type (2015-2026) Table South America Thrombin Sales (K Unit) of Major Company (2015-2020) Table South America Thrombin Sales Market Share of Major Company (2015-2020) Table South America Thrombin Sales Value (Million USD) of Major Company (2015-2020) Figure South America Thrombin Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Thrombin Sales Value Share of Major Company (2015-2020) Table South America Thrombin Price (USD/Unit), by Type (2019-2020) Table South America Thrombin Sales (Unit) by Type (2015-2026) Figure South America Thrombin Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Thrombin Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Thrombin Figure Cost Structure of Thrombin in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Thrombin Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Thrombin Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table ?Pfizer Profiles Table ?Pfizer Thrombin Product Introduction Table ?Pfizer Thrombin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ?Pfizer SWOT Analysis Table ????Johnson & Johnson Services Profiles Table ????Johnson & Johnson Services Thrombin Product Introduction Table ????Johnson & Johnson Services Thrombin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Johnson & Johnson Services SWOT Analysis Table ????Octapharma Profiles Table ????Octapharma Thrombin Product Introduction Table ????Octapharma Thrombin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Octapharma SWOT Analysis Table ????Baxter Profiles Table ????Baxter Thrombin Product Introduction Table ????Baxter Thrombin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Baxter SWOT Analysis Table ????Bayer Profiles Table ????Bayer Thrombin Product Introduction Table ????Bayer Thrombin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Bayer SWOT Analysis Table ????CSL Profiles Table ????CSL Thrombin Product Introduction Table ????CSL Thrombin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????CSL SWOT Analysis Table ????Grifols Profiles Table ????Grifols Thrombin Product Introduction Table ????Grifols Thrombin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Grifols SWOT Analysis Table ????GE Healthcare Profiles Table ????GE Healthcare Thrombin Product Introduction Table ????GE Healthcare Thrombin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????GE Healthcare SWOT Analysis Table ????Hualan Biological Profiles Table ????Hualan Biological Thrombin Product Introduction Table ????Hualan Biological Thrombin Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
